Department of Anatomy, Showa University School of Medicine Tokyo, Japan ; Center for Biotechnology, Showa University Tokyo, Japan.
Front Endocrinol (Lausanne). 2012 Nov 23;3:145. doi: 10.3389/fendo.2012.00145. eCollection 2012.
Pituitary adenylate cyclase-activating polypeptide (PACAP), which is found in 27- or 38-amino acid forms, belongs to the VIP/glucagon/secretin family. PACAP and its three receptor subtypes are expressed in neural tissues, with PACAP known to exert a protective effect against several types of neural damage. The retina is considered to be part of the central nervous system, and retinopathy is a common cause of profound and intractable loss of vision. This review will examine the expression and morphological distribution of PACAP and its receptors in the retina, and will summarize the current state of knowledge regarding the protective effect of PACAP against different kinds of retinal damage, such as that identified in association with diabetes, ultraviolet light, hypoxia, optic nerve transection, and toxins. This article will also address PACAP-mediated protective pathways involving retinal glial cells.
垂体腺苷酸环化酶激活肽(PACAP)有 27 个或 38 个氨基酸形式,属于 VIP/胰高血糖素/分泌素家族。PACAP 及其三种受体亚型在神经组织中表达,已知 PACAP 对多种类型的神经损伤具有保护作用。视网膜被认为是中枢神经系统的一部分,而视网膜病变是导致严重和难以治愈的视力丧失的常见原因。这篇综述将探讨 PACAP 及其受体在视网膜中的表达和形态分布,并总结目前关于 PACAP 对不同类型的视网膜损伤(如与糖尿病、紫外线、缺氧、视神经横断和毒素相关的损伤)的保护作用的知识状态。本文还将讨论涉及视网膜神经胶质细胞的 PACAP 介导的保护途径。